In vivo negative regulation of SARS-CoV-2 receptor, ACE2, by interferons and its genetic control (2021)
Attributed to:
Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.16559.1
Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.16559.1
Type: Journal Article/Review
Parent Publication: Wellcome Open Research